-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OgDD6uvjFpDmLTNhTzlEJM22JYMNVzttbX/kZ6DRcc/FOsTz7GAG4Q8g5kRdC0k9 miLKQ/ssUuB08W74hf0mUg== 0000936392-06-000103.txt : 20060210 0000936392-06-000103.hdr.sgml : 20060210 20060210134132 ACCESSION NUMBER: 0000936392-06-000103 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060116 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20060210 DATE AS OF CHANGE: 20060210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AASTROM BIOSCIENCES INC CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22025 FILM NUMBER: 06597062 BUSINESS ADDRESS: STREET 1: 24 FRANKL LLOYD WRIGHT DR STREET 2: PO BOX 376 CITY: ANN ARBOR STATE: MI ZIP: 48106 BUSINESS PHONE: 7349305555 8-K/A 1 a17248e8vkza.htm FORM 8-K/A e8vkza
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (date of earliest event reported):
January 16, 2006
Aastrom Biosciences, Inc.
(Exact name of registrant as specified in its charter)
         
Michigan
(State or other
jurisdiction of
incorporation) 		  0-22025
(Commission File No.) 		  94-3096597
(I.R.S. Employer
Identification No.)
24 Frank Lloyd Wright Drive
P.O. Box 376
Ann Arbor, Michigan 48106
(Address of principal executive offices)
Registrant’s telephone number, including area code:
(734) 930-5555
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 5.02 Departure of Directors or Principal Executive Officers; Election of Directors; Appointment of Principal Officers.
SIGNATURES

Table of Contents

Item 5.02 Departure of Directors or Principal Executive Officers; Election of Directors; Appointment of Principal Officers.
     Aastrom Biosciences, Inc. previously announced the election of Robert L. Zerbe to the Board of Directors. At the time of his election, the Board of Directors had not yet determined the committees on which Dr. Zerbe would serve.
     The Board of Directors has now determined that Dr. Zerbe will serve on the Governance and Nominating Committee.
SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 10, 2006
         
  AASTROM BIOSCIENCES, INC.
 		  
  By:   /s/ Gerald D. Brennan, Jr.    
    Gerald D. Brennan, Jr.   
    Vice President, Administrative and
Financial Operations; Chief Financial
Officer 		  
 

2 

-----END PRIVACY-ENHANCED MESSAGE-----